Robins-Browne et al., 1991 - Google Patents
Pathogenicity of Yersinia kristensenii for miceRobins-Browne et al., 1991
View PDF- Document ID
- 2710535473711649799
- Author
- Robins-Browne R
- Cianciosi S
- Bordun A
- Wauters G
- Publication year
- Publication venue
- Infection and immunity
External Links
Snippet
Forty-seven strains of Yersinia kristensenii from widely differing sources, representing all known O serogroups of this species, were investigated for virulence with a variety of animal and in vitro assays. Twenty-four (51%) of the isolates were lethal for mice pretreated with …
- 241001135251 Yersinia kristensenii 0 title abstract description 61
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—PROCESSES USING MICRO-ORGANISMS
- C12R1/00—Processes using micro-organisms
- C12R1/01—Processes using micro-organisms using bacteria or actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Bacteriophages
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI100945B (en) | A method of preparing a Shigella vaccine strain | |
| Minshew et al. | Association of hemolysin production, hemagglutination of human erythrocytes, and virulence for chicken embryos of extraintestinal Escherichia coli isolates | |
| Bottone | Yersinia enterocolitica: the charisma continues | |
| Chen et al. | The role of pgaC in Klebsiella pneumoniae virulence and biofilm formation | |
| US5436001A (en) | Live, avirulent Salmonella choleraesuis vaccine used for inducing an immune response in pigs | |
| Corbel | Microbiology of the genus Brucella | |
| US5580557A (en) | Live, avirulent salmonella choleraesuis vaccine used for inducing an immune response in animals | |
| DE60112413T2 (en) | SSA INACTIVATED SALMONELLA VACCINES | |
| CN110129280B (en) | Wide-cracking spectrum vibrio alginolyticus bacteriophage and composition, kit and application thereof | |
| US11412760B2 (en) | Escherichia coli bacteriophage Esc-COP-7, and use thereof for suppressing proliferation of pathogenic Escherichia coli | |
| JPH0440330B2 (en) | ||
| Robins-Browne et al. | Pathogenicity of Yersinia kristensenii for mice | |
| Field et al. | The chicken embryo as a model for campylobacter invasion: comparative virulence of human isolates of Campylobacter jejuni and Campylobacter coli | |
| Kirov et al. | Electron microscopic examination of factors influencing the expression of filamentous surface structures on clinical and environmental isolates of Aeromonas veronii biotype sobria | |
| Al-Jumaili et al. | A method of enhancing verocytotoxin production by Escherichia coli | |
| Wooley et al. | Characteristics of conjugative R-plasmids from pathogenic avian Escherichia coli | |
| Adler et al. | The genus leptospira | |
| Schiemann | Yersinia enterocolitica in drinking water | |
| Stewart et al. | Studies on the virulence of Aerococcus viridans (var.) homari, the causative agent of gaffkemia, a fatal disease of homarid lobsters | |
| US11213050B2 (en) | Escherichia coli bacteriophage Esc-COP-9 and use for inhibiting proliferation of pathogenic Escherichia coli thereof | |
| Green et al. | Fever and the control of gram-negative bacteria | |
| US6905691B1 (en) | Vaccines containing attenuated bacteria | |
| EP1037664B1 (en) | Vaccines containing attenuated bacteria | |
| Baron et al. | Genetic transformation of pilation and virulence into Neisseria gonorrhoeae T4 | |
| JP4081515B2 (en) | Vaccine for enterococci in fish |